Role of risk stratification by SPECT, PET, and hybrid imaging in guiding management of stable patients with ischaemic heart disease: expert panel of the EANM cardiovascular committee and EACVI(260 visite)(PDF privato167 visite) Acampa W, Gaemperli O, Gimelli A, Knaapen P, Schindler TH, Verberne HJ, Zellweger MJ
Impact factor: 4.293, Impact factor a 5 anni: 4.145
Url: Non disponibile.
Parole chiave: Risk Stratification, Spect, Hybrid Imaging,
*** IBB - CNR ***
1. Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A et al. ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013;34:2949–3003.
2. IskandrianAE,Hage F, ShawLJ,Mahmarian JJ,BermanDS. Serialmyocardial perfusion imaging: deﬁning a signiﬁcant change and targeting management decisions. JACC Cardiovasc Imaging 2014;1:79–96.
3. Flotats A, Knuuti J, Gutberlet M, Marcassa C, Bengel FM, Kaufmann PA et al. A joint position statement by the European Association of Nuclear Medicine (EANM), the European Society of Cardiac Radiology (ESCR) and the European Council of Nuclear Cardiology (ECNC). Eur J Nucl Med Mol Imaging 2011;1:201–12.
4. Canto JG, KiefeCI, RogersWJ, Peterson ED, Frederick PD, FrenchWJ et al.Number of coronary heart disease risk factors and mortality in patients with ﬁrst myocardial infarction. JAMA 2011;306:2120–7.
5. FerketBS,GendersTS,Colkesen EB,Visser JJ, Spronk S, Steyerberg EWet al. Systematic review of guidelines on imaging of asymptomatic coronary artery disease. J Am Coll Cardiol 2011;57:1591–600.
6. Hendel RC, Berman DS, Di Carli MF, Heidenreich PA, Henkin RE, Pellikka PA et al. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate Use Criteria for Cardiac Radionuclide Imaging: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the AmericanHeart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine. J Am Coll Cardiol 2009;53:2201–29.
7. Anand DV, Lim E, Hopkins D, Corder R, Shaw LJ, Sharp P et al. Risk stratiﬁcation in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy.Eur Heart J 2006;27:713–21.
8. Chang SM, Nabi F, Xu J, Peterson LE, Achari A, Pratt CM et al. The coronary artery calcium score and stress myocardial perfusion imaging provide independent and complementary prediction of cardiac risk. J Am Coll Cardiol 2009;54:1872–82.
9. Kral BG, Becker LC, Vaidya D, Yanek LR, Becker DM. Silent myocardial ischaemia and long-term coronary artery disease outcomes in apparently healthy people from families with early-onset ischaemic heart disease. EurHeart J 2011;32:2766–72.
10. Blumenthal RS, Becker DM, Yanek LR, Moy TF, Michos ED, Fishman EK et al. Comparison of coronary calcium and stress myocardial perfusion imaging in apparently healthy siblings of individuals with premature coronary artery disease. Am J Cardiol 2006;97:328–33.
11. Dayanikli F,GrambowD,MuzikO,Mosca L, RubenﬁreM, SchwaigerM. Early detection of abnormal coronary ﬂowreserve in asymptomaticmen at high risk for coronary artery disease using positron emission tomography. Circulation 1994;90:808–17.
12. Shaw LJ, Iskandrian A. Prognostic value of gatedmyocardial perfusion SPECT. J Nucl Cardiol 2004;2:171–85.
13. ElhendyA, SchinkelA, Bax JJ, vanDomburg RT, PoldermansD. Long-termprognosis after a normal exercise stress Tc-99msestamibi SPECT study. JNucl Cardiol 2003;10:261–6.
14. Klocke FJ,BairdMG, LorellBH, BatemanTM,Messer JV,BermanDS et al.ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995Guidelines for theClinicalUse ofCardiacRadionuclide Imaging). Circulation 2003;0:1404–18.
15. Abidov A, Bax JJ, Hayes SW, Hachamovitch R, Cohen I, Gerlach J et al. Transient ischemic dilation ratio of the left ventricle is a signiﬁcant predictor of future cardiac events in patients with otherwise normal myocardial perfusion SPECT. J Am Coll Cardiol 2003;42:1818–25.
16. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival beneﬁt associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003;107:2900–7.
17. Shaw LJ, Berman DS, Maron DJ, Mancini GBJ, Hayes SW, Hartigan PM et al.Optimal medical therapy with or without percutaneous coronary intervention to reduce is chemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 2008;
19. Herzog BA,Husmann L, Valenta I,GaemperliO, Siegrist PT, Tay FMet al. Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary ﬂow reserve. J Am Coll Cardiol 2009;54:150–6.
20. NamdarM,Hany TF, Koepﬂi P, Siegrist PT, Burger C,WyssCA et al. Integrated PET/CT for the assessment of coronary artery disease: a feasibility study. JNuclMed 2005;46:930–5.
21. Kajander S, Joutsiniemi E, Saraste M, Pietila¨ M, Ukkonen H, Saraste A et al. Cardiac positron emission tomography/computed tomography imaging accurately detects anatomically and functionally signiﬁcant coronary artery disease. Circulation 2010;122:603–13.
22. Danad I, Raijmakers PG,Harms HJ, van Kuijk C, van RoyenN,DiamantMet al. Effect of cardiac hybrid 15O-water PET/CT imaging on downstream referral for invasive coronary angiography and revascularization rate. Eur Heart J Cardiovasc Imaging 2014;15:170–9.
23. KimH-L, KimY-J, Lee S-P, Park E-A, Paeng J-C, KimH-K et al. Incremental prognostic value of sequential imaging of single-photon emission computed tomography and coronary computed tomography angiography in patients with suspected coronary artery disease. Eur Heart J Cardiovasc Imaging 2014;15:878–85.
24. DoukkyR,HayesK, FroggeN, BalakrishnanG,DontarajuVS,RangelMOet al. Impact of appropriate use on the prognostic value of single-photon emission computed tomography myocardial perfusion imaging. Circulation 2013;128:1634–43.
25. Hachamovitch R, Hayes S, Friedman JD, Cohen I, Shaw LJ, Germano G et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: what is thewarranty period of a normal scan? J AmColl Cardiol 2003;41:1329–40.
26. Mahmarian JJ, ShawLJ, FilipchukNG,DakikHA, Iskander SS, Ruddy TDet al. A multinational study to establish the value of early adenosine technetium-99m sestamibi myocardial perfusion imaging in identifying a low-risk group for early hospital discharge after acute myocardial infarction. J Am Coll Cardiol 2006;48:2448–57.
27. Zellweger MJ, Dubois EA, Lai S, Shaw LJ, Amanullah AM, Lewin HC et al. Risk stratiﬁcation in patients with remote priormyocardial infarction using rest-stressmyocardial perfusion SPECT: prognostic value and impact on referral to early catheterization. J Nucl Cardiol 2002;9:23–32.
28. Wolk MJ, Bailey SR, Doherty JU, Douglas PS, Hendel RC, Kramer CM et al. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American college of cardiology foundation appropriate use criteria task force, American heart association, American society of echocardiography, American society of nuclear cardiology, heart failure society of America, heart rhythm society, society for cardiovascular angiography and interventions, society of cardiovascular computed tomography, society for cardiovascular magnetic resonance, and society of thoracic surgeons. J Am Coll Cardiol 2014;63:380–406.
29. ZellwegerMJ, LewinHC, Lai S,Dubois EA, Friedman JD, Germano G et al.When to stress patients after coronary artery bypass surgery? Risk stratiﬁcation in patients early and late post-CABG using stress myocardial perfusion SPECT: implications of appropriate clinical strategies. J Am Coll Cardiol 2001;37:144–52.
30. Small GR, Yam Y, Chen L, Ahmed O, Al-Mallah M, Berman DS et al. Prognostic assessment of coronary artery bypass patients with 64-slice computed tomography angiography: anatomical information is incremental to clinical risk prediction. JAm Coll Cardiol 2011;58:2389–95.
31. McMurray JJ,Adamopoulos S,Anker SD,AuricchioA, BohmM,DicksteinKet al. Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for theDiagnosis and Treatment of Acute and ChronicHeart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012;33:1787–847.
32. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002;39:1151–8.
33. Bonow RO,MaurerG, Lee KL, Holly TA, Binkley PF,Desvigne-Nickens P et al. Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med 2011;364:1617–25.
34. Beanlands RS, Nichol G, Huszti E, Humen D, Racine N, Freeman M et al. PARR-2 Investigators. F-18-ﬂuorodeoxyglucose positron emission tomography imaging assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J Am Coll Cardiol 2007;50:2002–12.
35. Ling LF, Marwick TH, Flores DR, Jaber WA, Brunken RC, Cerqueira MD et al. Identiﬁcation of therapeutic beneﬁt from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium. Circ Cardiovasc Imaging 2013;6:363–72.
36. Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA et al. ADMIRE-HF Investigators. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. JAm Coll Cardiol 2010;55:2212–21.
37. Shaw LJ, Mieres JH, Hendel RH, BodenWE, Gulati M, Veledar E et al. Comparative effectiveness of exercise electrocardiographywith orwithoutmyocardial perfusion single photon emission computed tomography in women with suspected coronary artery disease: Results fromthe what is the optimal method for ischemia evaluation in women (women) trial. Circulation 2011;124:1239–49.
38. Hachamovitch R, Berman DS, Kiat H, Bairey CN, Cohen I, Cabico A et al. Effective risk stratiﬁcation using exercise myocardial perfusion spect in women: Gender-related differences in prognostic nuclear testing. J Am Coll Cardiol 1996;28:34–44.
39. Kay J,Dorbala S,GoyalA, FazelR,DiCarliMF, EinsteinAJ et al. Inﬂuence of sexon risk stratiﬁcationwith stressmyocardial perfusion rb-82 positron emission tomography: Results from the pet (positron emission tomography) prognosis multicenter registry. J Am Coll Cardiol 2013;62:1866–76.
40. Murthy VL,NayaM, Taqueti VR, Foster CR,GaberM,Hainer J et al. Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation 2014;129:2518–27.
41. Schindler TH, Campisi R, Dorsey D, Prior JO, Olschewski M, Sayre J et al. Effect of hormone replacement therapy on vasomotor function of the coronary microcirculation in post-menopausalwomenwithmedically treated cardiovascular risk factors. Eur Heart J 2009;30:978–86.
42. Haffner SM, Lehto S, Ro¨nnemaa T, Pyo ¨ra ¨la ¨ K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229–34.
43. Berman DS, Kang X, Hayes SW, Friedman JD, Cohen I, Abidov A et al. Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol 2003;41:1125–33.
44. Young LH,Wackers FJ,ChyunDA,Davey JA, Barrett EJ, Taillefer Ret al. Investigators. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA 2009;301:1547–55.
45. AcampaW, Petretta M, Daniele S, Del Prete G, Assante R, Zampella E et al. Incremental prognostic value of stress myocardial perfusion imaging in asymptomatic diabetic patients. Atherosclerosis 2013;227:307–12.
46. ZellwegerMJ,MaraunM,Osterhues HH, Keller U,Mu¨ller-Brand J, Jeger R et al. Progression to overt or silent CAD in asymptomatic patients with diabetes mellitus at high coronary risk: main ﬁndings of the prospective multicenter BARDOT trial with a pilot randomized treatment substudy. JACC Cardiovasc Imaging 2014;7:
47. American Diabetes Association. Executive summary: Standards of medical care in diabetes--2014. Diabetes Care 2014;37:S5–13.
48. Authors/Task ForceM, Ryden L,Grant PJ,Anker SD, BerneC,Cosentino F et al. guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the easd: The task force on diabetes, pre-diabetes, and cardiovascular diseases of the european society of cardiology (esc) and developed in
49. Murthy VL,NayaM, Foster CR,GaberM,Hainer J, Klein J et al. Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation 2012;126:1858–68.
50. Schindler TH, Cadenas J, Facta AD, Li Y,OlschewskiM, Sayre J et al. Improvement in coronary endothelial function is independently associated with a slowed progression of coronary artery calciﬁcation in type 2 diabetes mellitus. Eur Heart J 2009;30:3064–73.
51. Lee PY, Alexander KP, Hammill BG, Pasquali SK, Peterson ED. Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA 2001;286:708–13.
52. Uren NG, Camici PG, Melin JA, Bol A, de Bruyne B, Radvan J et al. Effect of aging on myocardial perfusion reserve. J Nucl Med 1995;36:2032–20.
53. Hesse B, Diaz LA, Snader CE, Blackstone EH, Lauer MS. Complete bundle branch block as independent predictor of all-cause mortality: report of 7,073 patients referred for nuclear exercise testing. Am J Med 2001;110:253–9.
54. Masci PG, Marinelli M, Piacenti M, Lorenzoni V, Positano V, Lombardi M et al. Myocardial structural, perfusion, and metabolic correlates of left bundle branch block mechanical derangement in patients with dilated cardiomyopathy: a tagged cardiac magnetic resonance and positron emission tomography study. Circ Cardiovasc Imaging 2010;3:482–90.
Risk stratification has become increasingly important in the management of patients with suspected or known ischaemic heart disease (IHD). Recent guidelines recommend that these patients have their care driven by risk assessment. The purpose of this position statement is to summarize current evidence on the value of cardiac single-photon emission computed tomography, positron emission tomography, and hybrid imaging in risk stratifying asymptomatic or symptomatic patients with suspected IHD, patients with stable disease, patients after coronary revascularization, heart failure patients, and specific patient population. In addition, this position statement evaluates the impact of imaging results on clinical decision-making and thereby its role in patient management. The document represents the opinion of the European Association of Nuclear Medicine (EANM) Cardiovascular Committee and of the European Association of Cardiovascular Imaging (EACVI) and intends to stimulate future research in this field.
14 Records (13 escludendo Abstract e Conferenze). Impact factor totale: 35.742 (31.21 escludendo Abstract e Conferenze). Impact factor a 5 anni totale: 30.516 (25.891 escludendo Abstract e Conferenze).